To evaluate if HCT15, HCC2998, and HCT116 colon cancer cell lines responded differently to calpain‐2 inhibitor treatment in terms of NF‐κB nuclear localization, we carried out an EMSA. The gene discussed is NFKB1; the disease is colonic neoplasm.